Sur, D., A. Havasi, C. Lungulescu, S. Volovat, C. Burz, and A. Irimie. “Endoglin (CD105) As a Putative Prognostic Biomarker for Colorectal Cancer: A Systematic Review”. Medicine and Pharmacy Reports, May 2022, doi:10.15386/mpr-2120.